Two views of the immunologic effects of fludarabine.
Schilling
P J
PJ
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002051:Burkitt Lymphoma / Q000188:drug therapy; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000139:chemically induced*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine